EPAS1 targeting by miR-152-3p in Paclitaxel-resistant Breast Cancer

Background: Paclitaxel plays a pivotal role in the chemotherapy of breast cancer, but resistance to this drug is an important obstacle in the treatment. It is reported that microRNA-152-3p (miR-152-3p) is involved in tamoxifen resistance in breast cancer, but whether it is involved in paclitaxel res...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ying, Zhang, Mo, Lu, Man Man, Qu, Li Yuan, Xu, Si Guang, Li, Yong Zhen, Wang, Ming Yong, Zhu, Hui Fang, Zhang, Zhe Ying, He, Guo Yang, Yuan, Zhi Qing, Li, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477434/
https://www.ncbi.nlm.nih.gov/pubmed/32913475
http://dx.doi.org/10.7150/jca.46898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477434/
https://www.ncbi.nlm.nih.gov/pubmed/32913475
http://dx.doi.org/10.7150/jca.46898

Ejemplares similares